Bovine Respiratory Disease is the most common disease in cattle, impacting the lower respiratory system and producing bronchopneumonia, which can lead to deaths. It’s a multi-factorial syndrome which is triggered by the combination of a viral infection and a bacterial agent, and is amplified by stress. Mannheimia hemolytica, Pasteurella multocida, and Hemophilus somnus, are among the bacteria that cause Bovine Respiratory Disease, and so are viral agents such as bovine viral diarrhea (BVD), infectious bovine rhinotracheitis (IBR), parainfluenza type-3 virus (PI-3), and bovine respiratory syncytial virus (BRSV).
The global bovine respiratory disease treatment market is expected to grow as cattle production increases in response to rising demand for animal meat.
Get a Sample Copy of the market Report 2021 @
According to a 2016 study published in the Turkish Journal of Veterinary and Animal Sciences, bovine respiratory disease (BRD) is the most common disease in cattle, contributing for around 75% of morbidity and over 50% of cow deaths. In the near future, the rising prevalence of BRD among cattle is expected to propel the global bovine respiratory disease treatment market growth.
Cattle production is among the most important industries in the U.S., according to research issued by the United States Department of Agriculture (USDA) in 2016. It was valued at US$ 78.2 billion in 2015. As the population grows, so does the need for cow meat and milk products, which drives up the pace of cattle breeding. Inadvertently, increasing cow rearing boosts the prevalence of BRD in cattle. In the near future, this is expected to make a favorable atmosphere for the growth of the global bovine respiratory disease treatment market.
The global bovine respiratory disease treatment market is divided into three categories: disease, treatment type, and distribution channel.
Due to rising prevalence of bovine respiratory disease, North America is expected to account for the largest share in the global bovine respiratory disease treatment market.
Due to growing prevalence of bovine respiratory disease in the region, North America is expected to have a dominating position in the bovine respiratory disease treatment market. Bovine respiratory disease (BRD) is a global health concern that is most common among cattle in North America, according to the 2014 Bovine Respiratory Disease Symposium.
In the U.S., BRD is accountable for 70-80 % of all feedlot morbidity and 40-50 % of all deaths. Due to increased cattle rearing in China, the bovine respiratory disease market in Asia Pacific is expected to grow substantially. According to a 2017 report issued by the U.S. Department of Agriculture, China is the world’s second-largest exporter of beef meat.
Ask for PDF sample copy of the report @
Rising development of innovative treatment methods for Bovine respiratory diseases are expected to boost the global bovine respiratory diseases treatment market growth over the forecast period
Major players operating in the global bovine respiratory disease treatment market are Bimeda Animal Health, Elanco, Virbac Group, Bayer AG, Zoetis Inc., Merck & Co. Inc., Boehringer Ingelheim GmbH, and Vetoquinol.
Bayer introduced in 2015, Immunostimulant Zelnate, a bovine respiratory disease (BRD) treatment that successfully reduces BRD-related deaths and lung lesions in cattle. The U.S. Department of Agriculture has approved Zelnate, the first cytosine-phosphate-guanine (CpG) motif-based immunostimulant.
Reasons to Purchase this Report
• To gain an in-depth understanding of Bovine Respiratory Disease Treatment market globally
• To identify the on-going trends and anticipated growth in the next nine years
• To help industry consultants, Bovine Respiratory Disease Treatment market other stakeholders align their market-centric strategies
• To obtain research-based business decisions and add weight to presentations and marketing strategies
• To gain competitive knowledge of leading market players
Buy This Complete A Business Report With Flat US $2000 Off @
Table of Content
Global Bovine Respiratory Disease Treatment Market Research Report
Section 1: Global Bovine Respiratory Disease Treatment Industry Overview
Section 2: Global Economic Impact on Bovine Respiratory Disease Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Bovine Respiratory Disease Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Bovine Respiratory Disease Treatment Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027